13F filer · CIK 1826434
Tri Locum Partners LP
NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$813.2M
+$100.7M vs prior
Positions
19
New / sold out
5 / 3
Added / reduced
8 / 6
Turnover
32.7%
buys $297.9M · sells $249.8M
Top-10 weight
80.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASCENDIS PHARMA A/S | +258,740 | – | +$69.0M |
| New | ENLIVEN THERAPEUTICS INC | +866,716 | – | +$44.0M |
| Added | AXSOME THERAPEUTICS INC. | +157,192 | +253.1% | +$38.5M |
| Added | VERTEX PHARMACEUTICALS INC | +72,477 | +56.0% | +$36.0M |
| New | REVOLUTION MEDICINES INC | +151,822 | – | +$28.4M |
| Added | LLYELI LILLY & CO | +14,737 | +23.8% | +$17.7M |
| New | CYTOKINETICS INC | +194,000 | – | +$16.5M |
| Added | JAZZ PHARMACEUTICALS PLC | +63,057 | +39.7% | +$15.2M |
| Added | ARGENX SE | +9,961 | +31.5% | +$9.2M |
| Added | DEXCOM INC | +122,321 | +17.5% | +$8.2M |
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | THERMO FISHER SCIENTIFIC INC | -132,413 | -100.0% | $-65.1M |
| Sold out | ASCENDIS PHARMA A/S | -255,332 | -100.0% | $-58.4M |
| Reduced | INTUITIVE SURGICAL INC | -105,267 | -68.7% | $-41.9M |
| Sold out | NUVALENT INC | -308,506 | -100.0% | $-31.6M |
| Reduced | MADRIGAL PHARMACEUTICALS INC | -35,015 | -33.9% | $-18.8M |
| Reduced | UNITED THERAPEUTICS CORP DEL | -23,344 | -33.2% | $-12.6M |
| Reduced | DEFINIUM THERAPEUTICS INC | -206,592 | -55.9% | $-9.7M |
| Reduced | TEVA PHARMACEUTICAL INDS LTD | -274,173 | -26.9% | $-9.3M |
| Reduced | DIANTHUS THERAPEUTICS INC | -24,831 | -17.1% | $-2.4M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | JNJJOHNSON & JOHNSON | 424,945 | $107.9M | 13.27% |
| 2 | VERTEX PHARMACEUTICALS INCCOM | 201,791 | $100.2M | 12.33% |
| 3 | LLYELI LILLY & CO | 76,532 | $91.8M | 11.29% |
| 4 | ASCENDIS PHARMA A/SORD SHS | 258,740 | $69.0M | 8.49% |
| 5 | DEXCOM INCCOM | 820,479 | $55.3M | 6.80% |
| 6 | AXSOME THERAPEUTICS INC.COM | 219,308 | $53.7M | 6.60% |
| 7 | JAZZ PHARMACEUTICALS PLCSHS USD | 221,720 | $53.4M | 6.57% |
| 8 | ENLIVEN THERAPEUTICS INCCOM | 866,716 | $44.0M | 5.41% |
| 9 | ARGENX SESPONSORED ADR | 41,596 | $38.6M | 4.75% |
| 10 | MADRIGAL PHARMACEUTICALS INCCOM | 68,273 | $36.7M | 4.51% |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.